GT Biopharma, Inc. (GTBP)
0.6497
0.00 (0.00%)
USD |
NASDAQ |
Dec 12, 10:45
GT Biopharma Research and Development Expense (TTM): 4.026M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 7.624M |
| Geron Corp. | 81.32M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| SELLAS Life Sciences Group, Inc. | 15.73M |
| Xencor, Inc. | 225.67M |